Congenital chromosomal disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
757
|
47
|
0.100 |
None |
0.964 |
28 |
|
1990 |
2018 |
Adult Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
332
|
20
|
0.100 |
None |
1.000 |
26 |
|
1997 |
2020 |
Childhood Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
335
|
20
|
0.100 |
None |
1.000 |
26 |
|
1997 |
2020 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
1.000 |
21 |
|
1995 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.100 |
None |
1.000 |
20 |
3
|
2002 |
2019 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.100 |
None |
1.000 |
20 |
|
2000 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.100 |
None |
1.000 |
19 |
3
|
2002 |
2019 |
Complete Trisomy 21 Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
669
|
77
|
0.100 |
None |
0.941 |
17 |
|
1997 |
2019 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
644
|
23
|
0.100 |
None |
1.000 |
16 |
|
1996 |
2019 |
Blast Phase
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
299
|
14
|
0.100 |
None |
0.923 |
13 |
|
1993 |
2019 |
Childhood B Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
99
|
4
|
0.100 |
None |
0.923 |
13 |
|
1999 |
2019 |
Childhood Acute Myeloid Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
215
|
6
|
0.100 |
None |
1.000 |
12 |
|
1998 |
2017 |
Chronic myeloproliferative disorder
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
366
|
47
|
0.100 |
None |
1.000 |
11 |
|
2001 |
2016 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
1.000 |
10 |
|
2013 |
2019 |
Other alopecia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
39
|
104
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2017 |
Androgenetic Alopecia
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
112
|
107
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2017 |
Alopecia, Androgenetic, 2
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
39
|
104
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2017 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
2 |
7
|
2016 |
2019 |
Adult onset asthma
|
disease |
|
Disease or Syndrome
|
48
|
67
|
0.100 |
None |
1.000 |
2 |
1
|
2019 |
2019 |
Alopecia, Androgenetic, 3
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
39
|
104
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2017 |
Alopecia, Male Pattern
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
91
|
743
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2017 |
Alopecia, Androgenetic, 1
|
disease |
|
Disease or Syndrome
|
39
|
104
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2017 |
Juvenile-Onset Still Disease
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
171
|
41
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Phospholipid measurement
|
phenotype |
|
Laboratory Procedure
|
58
|
306
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Blood basophil count (lab test)
|
phenotype |
|
Laboratory Procedure
|
272
|
452
|
0.100 |
None |
1.000 |
1 |
5
|
2016 |
2016 |